chr2-176092852-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000523.4(HOXD13):c.-39G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,180,036 control chromosomes in the GnomAD database, including 873 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.046 ( 543 hom., cov: 33)
Exomes 𝑓: 0.0052 ( 330 hom. )
Consequence
HOXD13
NM_000523.4 5_prime_UTR
NM_000523.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.115
Genes affected
HOXD13 (HGNC:5136): (homeobox D13) This gene belongs to the homeobox family of genes. The homeobox genes encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, located on different chromosomes, consisting of 9 to 11 genes arranged in tandem. This gene is one of several homeobox HOXD genes located in a cluster on chromosome 2. Deletions that remove the entire HOXD gene cluster or the 5' end of this cluster have been associated with severe limb and genital abnormalities. Mutations in this particular gene cause synpolydactyly. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 2-176092852-G-C is Benign according to our data. Variant chr2-176092852-G-C is described in ClinVar as [Benign]. Clinvar id is 1228320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.154 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0460 AC: 6980AN: 151724Hom.: 542 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
6980
AN:
151724
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00689 AC: 17AN: 2466 AF XY: 0.00150 show subpopulations
GnomAD2 exomes
AF:
AC:
17
AN:
2466
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00516 AC: 5309AN: 1028202Hom.: 330 Cov.: 18 AF XY: 0.00483 AC XY: 2360AN XY: 489096 show subpopulations
GnomAD4 exome
AF:
AC:
5309
AN:
1028202
Hom.:
Cov.:
18
AF XY:
AC XY:
2360
AN XY:
489096
Gnomad4 AFR exome
AF:
AC:
3505
AN:
21134
Gnomad4 AMR exome
AF:
AC:
88
AN:
7320
Gnomad4 ASJ exome
AF:
AC:
6
AN:
12750
Gnomad4 EAS exome
AF:
AC:
0
AN:
24500
Gnomad4 SAS exome
AF:
AC:
4
AN:
19444
Gnomad4 FIN exome
AF:
AC:
12
AN:
20392
Gnomad4 NFE exome
AF:
AC:
1202
AN:
879286
Gnomad4 Remaining exome
AF:
AC:
472
AN:
40642
Heterozygous variant carriers
0
220
440
660
880
1100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0461 AC: 7002AN: 151834Hom.: 543 Cov.: 33 AF XY: 0.0448 AC XY: 3329AN XY: 74244 show subpopulations
GnomAD4 genome
AF:
AC:
7002
AN:
151834
Hom.:
Cov.:
33
AF XY:
AC XY:
3329
AN XY:
74244
Gnomad4 AFR
AF:
AC:
0.157128
AN:
0.157128
Gnomad4 AMR
AF:
AC:
0.0210216
AN:
0.0210216
Gnomad4 ASJ
AF:
AC:
0.000576701
AN:
0.000576701
Gnomad4 EAS
AF:
AC:
0.000194628
AN:
0.000194628
Gnomad4 SAS
AF:
AC:
0.000414422
AN:
0.000414422
Gnomad4 FIN
AF:
AC:
0.000380807
AN:
0.000380807
Gnomad4 NFE
AF:
AC:
0.00129656
AN:
0.00129656
Gnomad4 OTH
AF:
AC:
0.0336493
AN:
0.0336493
Heterozygous variant carriers
0
316
633
949
1266
1582
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at